High materiality7/10
Xenon Pharmaceuticals (XENE) PT Lowered to $90 at Jefferies
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies lowers XENE's price target to $90; current price around $36.94.
- Jefferies lowers XENE PT to $90; price $36.94.
Key facts
- 01
Target: $90
- 02
Posted price: $36.94
- 03
Analyst firm: Jefferies
- 04
Analyst: Andrew Tsai
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.